This Beaten-Down Artificial Intelligence (AI) Stock Just Got Some Great News: Time to Buy?

Artificial intelligence (AI) is taking over the world. Individuals and corporations are implementing the technology in their day-to-day lives and operations; governmental institutions are doing the same. The U.S. Food and Drug Administration (FDA) recently announced it would phase out animal testing in drug development in favor of other methods, including AI-based testing.That's good news for Recursion Pharmaceuticals (RXRX 3.67%), a biotech company that's already pioneering the use of AI in drug developmen ...